Invokana vs. Ozempic

See how Invokana and Ozempic compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Invokana is a once-daily oral tablet, while Ozempic is a once-weekly injection, so the two fit very different daily routines.

  • Both drugs carry FDA approvals beyond blood sugar control, but Invokana focuses on kidney and heart protection while Ozempic often adds meaningful weight loss as a side benefit.

  • Invokana's most common side effects involve genital and urinary infections, while Ozempic's are mostly gastrointestinal, like nausea and vomiting.

Invokana vs. Ozempic Drug Summary

Invokana

Invokana (canagliflozin) is an SGLT2 inhibitor that lowers blood sugar in type 2 diabetes by causing the kidneys to remove excess glucose through urine. It comes as a tablet taken by mouth once a day, usually before the first meal.

Ozempic

Ozempic (semaglutide) is a GLP-1 receptor agonist that lowers blood sugar in type 2 diabetes by slowing digestion and boosting insulin release after meals. It is given as a subcutaneous injection once a week, with the dose raised gradually over several weeks.

Invokana vs. Ozempic Side Effects

Invokana

Most common
Genital yeast infection (up to 11%)
Urinary tract infection (up to 6%)
Increased urination (up to 5%)
Male genital yeast infection (up to 4%)

Ozempic

Most common
Nausea (up to 20.3%)
Vomiting (up to 9.2%)
Diarrhea (up to 8.8%)
Abdominal pain (up to 7.3%)

Invokana vs. Ozempic Dosage

Invokana

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 100 mg once daily At the start
Maximum dose 100 mg once daily Same as starting
Dose changes None Fixed dose

Ozempic

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.25 mg once weekly Weeks 1-4
Maximum dose 2 mg once weekly If needed
Dose changes 3 increases Every 4 weeks

Invokana vs. Ozempic Indications

Invokana

Invokana is FDA-approved to improve blood sugar control in adults with type 2 diabetes, alongside diet and exercise. It also carries approvals to reduce the risk of major cardiovascular events and to slow the progression of diabetic kidney disease in appropriate patients.

  • Blood sugar control in type 2 diabetes, with diet and exercise

  • Reduce risk of major cardiovascular events in adults with type 2 diabetes and established heart disease

  • Reduce risk of kidney failure progression, CV death, and heart failure hospitalization in diabetic nephropathy

  • Not approved for type 1 diabetes

Ozempic

Ozempic is FDA-approved to improve blood sugar control in adults with type 2 diabetes, alongside diet and exercise. It is also approved to reduce major cardiovascular events in people with known heart disease, and to slow chronic kidney disease progression.

  • Blood sugar control in type 2 diabetes, with diet and exercise

  • Reduce risk of major cardiovascular events in adults with type 2 diabetes and known heart disease

  • Reduce risk of further kidney damage and cardiovascular death in chronic kidney disease

  • Off-label: weight loss in people without diabetes (not FDA-approved for this use)

Invokana vs. Ozempic Pros and Cons

Invokana

Invokana suits patients who prefer a daily pill over an injection and who also face diabetic kidney disease or cardiovascular risk. Genital infections are a common trade-off, and insurance coverage can be inconsistent.

Pros

  • Oral once-daily tablet, no injection required

  • Also approved to slow diabetic kidney disease progression

  • Also lowers risk of heart failure hospitalization

  • Lower typical list price than Ozempic ($550 to $830 per month vs. $935 to $1,043, before savings programs)

Cons

  • Common genital yeast infections, especially in women

  • Less weight loss on average than GLP-1 injections like Ozempic

  • Dose must be limited or avoided when kidney function is significantly reduced

  • Can increase risk of dehydration and low blood pressure

Ozempic

Ozempic appeals to patients who want strong blood sugar control along with a good chance of weight loss and added cardiovascular and kidney protection. Gastrointestinal side effects are common during dose increases, and the thyroid tumor warning requires caution in some patients.

Pros

  • Also approved to reduce major cardiovascular events in known heart disease

  • Also approved to slow chronic kidney disease progression

  • Often produces meaningful weight loss as an added benefit

  • One injection a week means fewer doses to remember than a daily pill

Cons

  • Boxed warning for thyroid C-cell tumors seen in animal studies

  • Common gastrointestinal side effects, especially nausea and vomiting

  • Not recommended for patients with severe gastroparesis

  • Higher typical list price than Invokana ($935 to $1,043 per month vs. $550 to $830, before savings programs)

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.